Trial Profile
Phase II trial to study the efficacy of seasonal influenza vaccine in cancer patients undergoing chemotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Nov 2020
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Afluria) (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 01 Nov 2020 Results published in the Supportive Care in Cancer
- 27 Apr 2011 New trial record